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Abstract 
A method for determining mRNA half-lives in the polymorphic fungus Candida al-
bicans is described. It employs growth in a defined medium, the inhibition of tran-
scription with thiolutin (10–20 μg/mL), and quantitative Northern blotting. The 
method is effective for the A72, SC5314, and CAI-4 strains of C. albicans, and for 
mRNAs that have a wide variety of decay rates and steady-state abundances. The 
range of half-lives detected (from 4–168 min) shows that this method is effective 
for mRNAs with widely varying half-lives. The mRNA decay rates obtained are com-
pared with those for orthologous mRNAs from Saccharomyces cerevisiae. This pro-
cedure should work for a broad range of C. albicans strains and can be adapted to 
other fungal species. 
Keywords: comparative mRNA stability, ACT1, ADH1, EFG1, PGK1, 18S rRNA, mRNA 
decay
Résumé 
Une méthode pour déterminer les demi-vies d’ARNm dans le champignon poly-
morphe Candida albicans est décrite. Il utilise la croissance dans un milieu défini, 
l’inhibition de la transcription avec la thiolutine (10–20 μg / mL) et le Northern 
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blot quantitatif. La méthode est efficace pour les souches A72, SC5314 et CAI-4 de 
C. albicans, et pour les ARNm qui ont une grande variété de taux de désintégration 
et d’abondances à l’état d’équilibre. La gamme de demi-vies détectées (de 4 à 168 
min) montre que cette méthode est efficace pour les ARNm avec des demi-vies très 
variables. Les taux de désintégration des ARNm obtenus sont comparés à ceux des 
ARNm orthologues de Saccharomyces cerevisiae. Cette procédure devrait fonction-
ner pour une large gamme de souches de C. albicans et peut être adaptée à d’autres 
espèces fongiques.
Mots-clés: stabilité comparative de l’ARNm, ACT1, ADH1, EFG1, PGK1, ARNr 18S, 
désintégration de l’ARNm
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Introduction 
The polymorphic fungus Candida albicans is a commensal, found in 
many different locations of the human body, that can become a major 
fungal pathogen in immunocompromised individuals. Because of its 
pathogenicity, C. albicans has become the 4th most common nosoco-
mial infection in the United States. However, current antifungal treat-
ments are only partly effective. Consequently, a significant number of 
patients with nosocomial C. albicans infections who are treated with 
current antifungals will die (Gudlaugsson et al. 2003; Macphail et al. 
2002). Candida albicans is eukaryotic, sharing many biological pro-
cesses with humans. Therefore, it is important to understand the reg-
ulation of gene expression of C. albicans to develop or improve treat-
ment methods (Berman and Sudbery 2002). 
The amount of protein that is synthesized by a cell depends on 
the rate of synthesis of the protein, which in turn depends on the 
steady-state level of the corresponding mRNA. The steady-state lev-
els of mRNAs are determined by 2 factors: the rate of synthesis of 
the specific mRNA, and the rate of decay of that mRNA. Thus, mRNA 
stability is an important aspect of the regulation of gene expression. 
Eukaryotic mRNA half-lives can vary from a few minutes in Saccha-
romyces cerevisiae to several hours in mammalian cells (Ross 1995). 
Herrick et al. (1990) reported that for S. cerevisiae, most of the mRNA 
half-lives are in the 3–45 min range. 
However, half-lives of individual C. albicans mRNAs have not been 
reported. Bulk half-lives for total poly(A)–containing RNA have been 
determined using the pulse– chase technique, and were found to be 
about 60 min (Bhattacharya and Datta 1975). This value is significantly 
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longer than that reported for S. cerevisiae (Herrick et al. 1990). In this 
paper, we describe the determination of mRNA half-lives of select C. 
albicans mRNAs that represent both stable and unstable mRNAs. The 
method works by shutting off the transcription of new mRNAs, us-
ing thiolutin, and then looking at the turnover of the already present 
messages via quantitative Northern blotting. The method is effective 
for all 3 of the C. albicans strains tested and for mRNAs that are pres-
ent in both low and high abundance. 
Materials and methods 
Candida albicans strains and growth media 
Three strains of Candida albicans were used: A72, SC5314, and CAI-4 
(ura3::imm434/ura3::imm434) (Fonzi and Irwin 1993). A72 and 
SC5314 are clinical isolates and SC5314 is the reference strain for the 
Candida genome sequence (Arnaud et al. 2005). SC5314 and CAI-4 
were obtained from Alexander Johnson, University of California at 
San Francisco. A72 was obtained from Patrick Sullivan, University of 
Otago, Dunedin, New Zealand, and A72 has been deposited with the 
American Type Culture Collection (Rockville, MD) as strain MYA-2430. 
All cultures were grown in either YPD or the defined glucose–phos-
phate–proline (GPP) (pH 4.8), which was supplemented with 50 μg/
mL uridine for CAI-4. YPD contains 1% yeast extract, 0.5% peptone, 
and 2% glucose. GPP contains, per liter: 20 g glucose, 1.15 g l-pro-
line, 0.55 g N-acetylglucosamine, 4 g KH2PO4, 3.2 g NaH2PO4, 0.5 g 
MgSO4·7H2O, 1 mg CuSO4·5H2O, 1 mg ZnSO4·7H2O, 1 mg MnCl2, 1 mg 
FeSO4, 20 μg biotin, 200 μg pyridoxine·HCl, and 200 mg thiamine·HCl 
(pH 4.8). The glucose (20% w/v) and l-proline (100 mmol/L) were 
autoclaved separately and added aseptically to the GPP to give a final 
volume of 1 L. 
Growth curves in the presence or absence of thiolutin 
Thiolutin (Pfizer compound CP-4,092) was kindly provided by Ed-
ward Pagani, Manager Research and Development Operations, Cen-
tral Research Division, Pfizer Inc. (Groton, Conn.). Thiolutin was sol-
ubilized to a final concentration of 10 mg/mL in dimethyl sulfoxide 
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(DMSO). All growth conditions were at 30 °C with shaking at 200 r/
min, using a G10 gyrotory shaker (New Brunswick Scientific Inc., New 
Brunswick, N.J.). An overnight culture of C. albicans was prepared in 
5 mL YPD or GPP. From that overnight culture, 1 mL was added to 40 
mL of prewarmed YPD or GPP in a 250 mL nephaloflask, and turbid-
ity readings were taken with the Klett–Summerson colorimeter (Klett 
Manufacturing Company Inc., New York), using a red filter, until the 
culture reached 250 Klett units (roughly 0.5 OD600). Then, 10 mL of 
culture was added to each of 3 prewarmed nephaloflasks. Thiolutin 
in DMSO was added to 2 separate flasks, at a final concentration of 10 
or 20 μg/mL, respectively. An equivalent amount of DMSO alone was 
added to a third flask (DMSO-only control). The remaining 10 mL in 
the original flask served as an untreated control. Klett readings were 
taken every 5 to 10 min for the first hour, and as needed thereafter. 
Viability counts were determined using a hemocytometer and meth-
ylene blue staining. 
Uridine incorporation 
3H-uridine incorporation followed the protocol described by Bini et 
al. (2002), with modifications. Candida albicans CAI-4 was grown in 
GPP, supplemented with 0.175 μg/mL of nonradioactive uridine to an 
OD600 of ca. 0.32. Portions (1.7 mL) of this culture were transferred to 
sterile 25 mL Erlenmeyer flasks and equilibrated for 5 min at 30 °C 
with shaking at 200 r/min. Radiolabeled uridine (5,6-3H, 37 Ci/mmol; 
MP Biomedicals Inc., Irvin, Calif.) was added to make 0.013 μCi/mL. 
Samples (10 μL) were collected in duplicate at 0, 10, 20, 40, and 60 
min, and transferred to capped eppendorf tubes containing 490 μL of 
unlabelled carrier cells (ca. 4 × 108 cells/mL), added to promote cen-
trifugal recovery of trichloroacetic acid (TCA) precipitates. A total of 
150 μL of cold 50% (w/v) TCA was added to each tube, to give a final 
concentration of 11.5% (w/v) TCA. Samples were vortexed, allowed 
to precipitate on ice for at least 5 min, and centrifuged at 15 000g, 
whereupon the supernatants were discarded. Pellets were resuspended 
in 25 μL of Tris–EDTA (pH. 8.0), placed in scintillation vials contain-
ing 2 mL of scintisafe F scintillation fluid (Fisher Scientific, Pittsburg, 
Penn.), and counted on an LS1701 liquid scintillation counter (Beck-
man Instruments, Fullerton, Calif.). 
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To assess thiolutin as a transcription inhibitor, after 60 min the cul-
ture was split into 3 flasks, each containing 500 μL of culture with, 
respectively, thiolutin 10 μg/mL in DMSO (0.1%), DMSO (0.1%), and 
no further additions. Samples (10 μL) were taken from each flask af-
ter 65, 70, 75, 80, 85, 90, 95, and 100 min and processed, as described 
above. 
mRNA half-lives 
Candida albicans CAI-4 cells were grown overnight at 30 °C in YPD 
or GPP, supplemented with 50 μg/mL uridine to an OD600 of 0.4–0.6. 
Thiolutin (10 mg/mL in DMSO) was added to a final concentration of 
10 μg/mL. Cells were then harvested at different time points after thi-
olutin was added, and total RNA was extracted using the hot phenol 
method (Kebaara et al. 2003). Equal amounts of RNA (15 μg) were re-
solved on 1.0% agarose–formaldehyde gels, and the RNA was trans-
ferred to GeneScreen Plus (NEN Life Science Products Inc., Boston, 
Mass.), using the capillary blot transfer protocol recommended by 
the manufacturer. The Northern blots were probed sequentially with 
ACT1, ADH1, EFG1, PGK1, and 18S DNA probes. The probes were pre 
pared using PCR with SC5314 genomic DNA; the primers are listed in 
Table 1. The probes were labeled with 32P using an oligolabelling kit 
(RadPrime DNA labeling system; Invitrogen, Life Technologies, Carls-
bad, Calif.). Northern blots were phosphorimaged using a Storm (Am-
ersham Pharmacia Biotech Inc., Piscataway, N.J.). Half-lives were de-
termined by plotting log10 of the percent mRNA remaining against 
time, using SigmaPlot 2000, v. 6.10 (SPSS Science, Chicago, Ill.). Half-
life measurements were done in triplicate. 
Table 1. Primers used to generate probe fragments, and sizes of the probe fragments.
Gene  5′ primer  3′ primer  Probe fragment 
    size (bp)
ACT1  AGTTATCGATAACGGTTCTG  AGATTTCCAGAATTTCACTC  1124
ADH1  CAAAAAGGATAATCCCGCAC  CTGGAGCAGTGACTTTAGCGTG  1145
EFG1  TTGACTACCAAGAATATAACC  CACTGGTAGCAGATATACTG  1128
PGK1  CAATCAAGCGATTATCAATTG  ATGTTACCATTTTCAGCAGA  1141
18S rRNA  TCAGTTATCGTTTATTTGAT  TTCCTCTAAATGACCAAGTTTG  1621
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Results 
Thiolutin inhibits C. albicans growth 
A series of known transcription inhibitors were tested for their ability 
to inhibit the growth of C. albicans. Thiolutin inhibited the growth of 
C. albicans strains CAI-4 (Fig. 1), SC5314, and A72 when added at 10–
20 μg/mL. It also inhibits the growth of the yeast S. cerevisiae strain 
Y166 (Jimenez et al. 1973) and strain DBY747 (Herrick et al. 1990) 
when present at 2–4 μg/mL, by reversibly inhibiting RNA synthesis. 
In contrast, actinomycin D, at concentrations up to 2 mg/mL, did not 
inhibit the growth of C. albicans. This inactivity by actinomycin D is 
in accord with the generalization that most fungi are impermeable to 
actinomycin D. 
Before conducting the C. albicans mRNA half-life experiments, it 
was important to determine the concentration of thiolutin needed for 
that particular strain and set of growth conditions. When grown in 
YPD at 30 °C, 10 μg/mL thiolutin was required to inhibit C. albicans 
CAI-4 (Fig. 1A); a higher concentration (20 μg/mL) was required for 
C. albicans A72 (data not shown). For CAI-4 in YPD (Fig. 1A), after the 
addition of 10 μg/mL thiolutin, there was a lag of about 25 min before 
the cells stopped growing. In contrast, when C. albicans CAI-4 was 
grown in the defined GPP with 50 μg/mL of uridine, the cells did not 
exhibit a lag period between thiolutin addition and growth inhibition, 
but they required 20 μg/mL of thiolutin to inhibit growth (Fig 1C and 
D). Similar observations were made with C. albicans SC5314 (20 μg/
mL thiolutin) and C. albicans A72 (20 μg/mL of thiolutin); there was a 
20–25 min lag period when grown in YPD but no lag period with GPP. 
Viability of C. albicans cells in the presence of thiolutin was ≥90% but 
in its absence was 100%. Viability of C. albicans cells was determined 
using a hemocytometer with methylene blue staining.  
Thiolutin treatment arrests transcription 
To determine whether the growth arrest following thiolutin treatment 
is accompanied by transcription inhibition, we measured the incor-
poration of 3H-uridine into TCA-precipitable RNA, as described else-
where (Bini et al. 2002). C. albicans CAI-4 incorporates 3H-uridine 
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when grown in GPP supplemented with as little as 0.175 μg/mL of un-
labelled uridine (Fig. 2), and the addition of thiolutin (10 μg/mL) in-
hibited 3H-uridine incorporation. A 10–15 min lag period was observed 
before inhibition was complete (Fig. 2), after which the level of TCA-
precipitable RNA remained fairly constant. As expected, cells grown in 
the absence of thiolutin continued to incorporate 3H-uridine (Fig. 2). 
Fig. 1. Effect of thiolutin on the growth of Candida albicans CAI-4. C. albicans CAI-4 
grown in YPD (A and B) or glucosephosphate-proline (GPP) supplemented with uri-
dine (C and D) in the presence or absence of thiolutin. The bottom panels (B and 
D) are expansions of the boxes shown in the upper panels. ♦, control; □, dimethyl 
sulfoxide (DMSO); Δ, thiolutin (10 μg/mL); ×, thiolutin (20 μg/mL); GPP, glucose-
phosphate-proline. Thiolutin curves are an average of 3 trials.
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mRNA half-lives 
mRNA half-lives of select transcripts were determined for C. albicans 
CAI-4 grown in both YPD and GPP supplemented with uridine (Table 
2; Fig. 3). The transcripts were selected to include mRNAs expected to 
be stable (ACT1 mRNA, which encodes actin, and PGK1 mRNA, which 
encodes phosphoglycerate kinase), unstable (EFG1 mRNA, which en-
codes enhanced filamentous growth factor, a transcription regulator), 
and of intermediate stability (ADH1 mRNA, which encodes alcohol de-
hydrogenase). The half-life of 18S rRNA was also determined because 
it is an RNA polymerase I transcript and it has been reported that thi-
olutin inhibits all 3 RNA polymerases in S. cerevisiae (Jimenez et al. 
1973). The mRNA half-lives were measured for 60 min for ADH1 and 
EFG1 mRNAs, and for 120 min for ACT1, ADH1, and PGK1 mRNAs. Fig-
ure 3 shows representative phosphorimages of PGK1 mRNA at differ-
ent times after the inhibition of transcription. mRNA half-lives were 
determined from the slopes of the lines plotting percent mRNA re-
maining against time after transcription arrest. The lag in growth in-
hibition observed when thiolutin was added to C. albicans CAI-4 in 
YPD was also observed when determining mRNA half-lives (Fig. 3A), 
although the lag was shorter (~10 min). There was also a short lag 
Fig. 2. Effect of thiolutin on RNA synthesis. Measurement of 3Huridine incorpo-
ration into C. albicans CAI-4 (a uridine auxotroph). Thiolutin (10 μg/mL in DMSO, 
▼) or DMSO (○), both added at 60 min (indicated by arrow). Untreated control (●).
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Fig. 3. PGK1 mRNA half-life in YPD (A) and in GPP supplemented with uridine (B). 
The phosphorimages show the PGK1 mRNA at different time points after the arrest 
of transcription using thiolutin. The time points are indicated above the phospho-
rimages. The percent mRNA remaining was calculated by dividing the volume of a 
particular band by the volume of the 0 min time point. The percent mRNA remain-
ing vs. time was plotted using SigmaPlot.
Table 2. Comparison of Candida albicans mRNA half-lives with previously determined
Saccharomyces cerevisiae mRNA half-lives. 
 C. albicans mRNA  S. cerevisiae mRNA 
 half-livesa (min) half-lives (min)
Transcript  30 °C  30 °C  36 °C  rpb1–1b  Reference
ACT1 mRNA  34.6  135  30  40  Li et al. 1999
ADH1 mRNA  33.3  —  —  33  Wang et al. 2002
EFG1/SOK2 mRNA  4.3  —  —  21  Wang et al. 2002
PGK1 mRNA  43.3  >100  —  45  Herrick et al. 1990
18S rRNA  168  —  —  —  —
a. C. albicans half-lives were done in YPD at 30 °C.
b. rpb1–1 is a temperature sensitive allele of RNA polymerase II (Nonet et al. 1987).
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period observed for mRNA half-lives in GPP (Fig. 3B), even though 
there was no lag period for growth inhibition under those conditions 
(Fig. 1C and 1D). Transcript half-lives in YPD at 30 °C were determined 
to be 34.6 ± 5 min for ACT1 mRNA, 43.3 ± 0.6 min for PGK1 mRNA, 
33.3 ± 3 min for ADH1 mRNA, 4.3 ± 1.2 min for EFG1 mRNA, and 168 
± 25 min for 18S rRNA. 
The half-lives of ADH1 and PGK1 mRNAs were also determined for 
CAI-4 grown in GPP supplemented with uridine. In this case, the ADH1 
mRNA half-life in GPP was 33 ± 4.7 min, consistent with the 33.3 ± 3 
min half-life determined in YPD. PGK1 mRNA half-life in GPP supple-
mented with uridine was 58 ± 12 min (Fig. 3B), whereas it was only 
43.3 ± 0.6 min in YPD (Fig. 3A). 
Discussion 
We have devised an effective method for determining mRNA half-lives 
in the dimorphic fungus C. albicans. No method for measuring Can-
dida mRNA half-lives has been reported to date. Because mRNA half-
life is an important gene regulatory mechanism, this method will be 
an essential new tool for the study of gene regulation in C. albicans. 
This method prevents new mRNA synthesis with the transcription in-
hibitor thiolutin. This procedure, adapted from one previously used 
for S. cerevisiae (Herrick et al. 1990), had to be validated for C. albi-
cans because of the distinctive features of C. albicans: unlike S. cerevi-
siae, it cannot uptake uracil; its genome contains ca. 2000 more genes 
than does that of S. cerevisiae; strains of C. albicans can behave very 
different physiologically; and C. albicans exhibits a temperature-reg-
ulated dimorphism, in that it usually grows as budding yeasts at 25–
30 °C and as mycelia at ≥37 °C (Odds 1988). For this last reason, the 
most common method for determining mRNA half-lives in S. cerevi-
siae (based on a 24–36 °C shift in a strain containing a thermolabile 
RNA polymerase II) would have limited utility in C. albicans, even if 
the corresponding temperature-sensitive mutant was available. The 
mRNA half-life method used here involves inhibiting transcription 
with thiolutin and then measuring mRNA accumulation at subsequent 
time points. 
Thiolutin is a purine analog and the inability of C. albicans to take 
up uracil, unlike S. cerevisiae, suggests that there is a fundamental 
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difference in nucleoside uptake between C. albicans and S. cerevi-
siae. We found that thiolutin inhibited the growth of 3 C. albicans 
strains: CAI-4 (Fig. 1), SC5314, and A72. Further, for C. albicans CAI-
4, we showed that growth inhibition was accompanied by transcrip-
tion inhibition (Fig. 2). These strains were chosen because CAI-4 is 
routinely used for molecular genetic and genomic studies (Magee et 
al. 2003), SC5314 is the reference strain for the Candida genome se-
quence (Arnaud et al. 2005), and A72 is a well-characterized farnesol-
producing and farnesol-responsive strain. Thus, the use of thiolutin 
to inhibit transcription will be of broad utility to Candida research-
ers. Further, our method should be adaptable to other fungal species 
sensitive to thiolutin. 
Unstable mRNAs tend to be less abundant than stable mRNAs; thus, 
mRNA half-lives are important in determining both the abundance of 
a specific message and the way a particular gene is controlled. Thiolu-
tin has been used successfully to measure mRNA half-lives in S. cere-
visiae, and the decay measurements made with thiolutin were com-
parable to those done with other methods (Herrick et al. 1990). The 
method described here can be used to determine mRNA half-lives in all 
strains of C. albicans tested, with cells grown at many different tem-
peratures in both minimal and rich media. However, in all cases, it is 
important to tailor the thiolutin concentration to the strain of C. albi-
cans and the growth conditions being studied. The choice of growth 
conditions might also determine the length of the lag period observed 
after thiolutin is added. For C. albicans CAI-4 grown in YPD, there was 
a lag period of 25 min before growth inhibition (Fig. 1B), but the lag 
period was only ~10 min before the inhibition of transcription (Fig. 
3A). In contrast, for C. albicans CAI-4 grown in the defined GPP me-
dium, there was no detectable lag before growth inhibition (Fig. 1C 
and 1D) and a very short lag before transcription inhibition (Fig. 3B). 
Similar mRNA half-life measurements in S. cerevisiae have shown a 
lag period between thiolutin addition and transcription inhibition of 
about 10 min (Herrick et al. 1990). 
We have determined the half-lives of 5 transcripts that have vary-
ing stabilities. Based on their known stabilities in S. cerevisiae (Her-
rick et al. 1990), ACT1 and PGK1 mRNAs were expected to be stable; 
they were found to be long lived in C. albicans as well (Table 2). In-
terestingly, the half-lives of PGK1 and ADH1 mRNAs were 43.3 and 
33.3 min, respectively, in C. albicans, compared with 45 and 33 min, 
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respectively, in S. cerevisiae (Herrick et al. 1990; Wang et al. 2002). 
However, the PGK1 mRNA half-life of 43.3 min in YPD was increased 
to 58 min when the cells were grown in GPP. This shows that mRNAs 
of the same transcript can have different half-lives, depending on the 
growth conditions. The ADH1 and ACT1 mRNA half-lives were also 
similar to those for S. cerevisiae (Table 2). ADH1 mRNA showed inter-
mediate stability, whereas EFG1 mRNA, which encodes a transcription 
factor, was unstable, as was expected because of its regulatory func-
tion (Stoldt et al. 1997). This range of half-lives, from 4 to 168 min 
(Table 2), shows that this method can be used to determine the sta-
bility of mRNAs with widely varying half-lives. It also allows the ten-
tative conclusion that mRNA half-lives are generally equivalent for S. 
cerevisiae and C. albicans. Finally, the method of inhibiting transcrip-
tion with thiolutin can also be used with other RNA detection meth-
ods, such as RNase protection or quantitative reverse tran scription 
(RT)-PCR. In both cases, thiolutin would be added to growing cells, 
RNA would be extracted, and the amount of RNA remaining would be 
determined at successive time points. Quantitative Northern blotting 
is currently the method of choice, at least initially, because the size of 
the RNA and the potential presence of multiple bands can be detected 
on Northern blots. mRNA size is one indicator that the correct mRNA 
is being detected. Multiple bands could arise from RNA isoforms or 
cross hybridization to related or similar RNAs. It is more difficult to 
discriminate between different RNA isoforms with RT-PCR or RNase 
protection. 
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